Goldman Sachs’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Goldman Sachs’s Portfolio CYNA Stock Details CYNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-27,267	Closed	-$1.1M	–	7309
2016 Q3	$1.1M	Buy	+27,267	New	+$673K	﹤0.01%	4321
2015 Q4	–	Sell	-12,929	Closed	-$209K	–	7556
2015 Q3	$209K	Buy	+12,929	New	+$210K	﹤0.01%	5988

Goldman Sachs's CYNA Position: Q4 2016 in Review

Goldman Sachs sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 27,267 shares — an estimated $1.1M sold.

Goldman Sachs first reported a position in CYNA in Q3 2015 and held it in 2 quarters. The position peaked at $1.1M in Q3 2016. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

Goldman Sachs reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
Goldman Sachs sold 27,267 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $1.1M.
Goldman Sachs first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q3 2015 and held it in 2 quarters.
Goldman Sachs's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $1.1M in Q3 2016.
0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on Goldman Sachs's 13F filing for Q4 2016, filed 14 Feb 2017.